Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chikako Fukukawa

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Future Oncology (London, England)|March 25, 2006
Molecular target therapy for synovial sarcomaChikako Fukukawa, Yusuke Nakamura, Toyomasa Katagiri
Genes, Chromosomes & Cancer|July 1, 2010
Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cellsChikako Fukukawa, Koji Ueda, Toshihiko Nishidate, et al.
Cancer Letters|July 26, 2005
pp32/ I-1(PP2A) negatively regulates the Raf-1/MEK/ERK pathwayChikako Fukukawa, Nobuhiro Tanuma, Tadashi Okada, et al.
International Journal of Oncology|September 3, 2010
Involvement of C12orf32 overexpression in breast carcinogenesisJung-Won Kim, Chikako Fukukawa, Koji Ueda, et al.
International Journal of Oncology|February 11, 2005
The oncoprotein I-2PP2A/SET negatively regulates the MEK/ERK pathway and cell proliferationChikako Fukukawa, Hiroshi Shima, Nobuhiro Tanuma, et al.
Cancer Science|February 15, 2008
Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10Chikako Fukukawa, Hirofumi Hanaoka, Satoshi Nagayama, et al.
Oncogene|July 12, 2005
Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomasSatoshi Nagayama, Chikako Fukukawa, Toyomasa Katagiri, et al.
Cancer Science|May 13, 2009
Involvement of G-patch domain containing 2 overexpression in breast carcinogenesisMeng-Lay Lin, Chikako Fukukawa, Jae-Hyun Park, et al.
Cancer Science|January 13, 2009
Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumorsSatoshi Nagayama, Eiji Yamada, Yoshiki Kohno, et al.
International Journal of Oncology|September 3, 2009
Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cellsMasahiko Ajiro, Toyomasa Katagiri, Koji Ueda, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Future Oncology (London, England)|March 25, 2006
Molecular target therapy for synovial sarcomaChikako Fukukawa, Yusuke Nakamura, Toyomasa Katagiri
Genes, Chromosomes & Cancer|July 1, 2010
Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cellsChikako Fukukawa, Koji Ueda, Toshihiko Nishidate, et al.
Cancer Letters|July 26, 2005
pp32/ I-1(PP2A) negatively regulates the Raf-1/MEK/ERK pathwayChikako Fukukawa, Nobuhiro Tanuma, Tadashi Okada, et al.
International Journal of Oncology|September 3, 2010
Involvement of C12orf32 overexpression in breast carcinogenesisJung-Won Kim, Chikako Fukukawa, Koji Ueda, et al.
International Journal of Oncology|February 11, 2005
The oncoprotein I-2PP2A/SET negatively regulates the MEK/ERK pathway and cell proliferationChikako Fukukawa, Hiroshi Shima, Nobuhiro Tanuma, et al.
Cancer Science|February 15, 2008
Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10Chikako Fukukawa, Hirofumi Hanaoka, Satoshi Nagayama, et al.
Oncogene|July 12, 2005
Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomasSatoshi Nagayama, Chikako Fukukawa, Toyomasa Katagiri, et al.
Cancer Science|May 13, 2009
Involvement of G-patch domain containing 2 overexpression in breast carcinogenesisMeng-Lay Lin, Chikako Fukukawa, Jae-Hyun Park, et al.
Cancer Science|January 13, 2009
Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumorsSatoshi Nagayama, Eiji Yamada, Yoshiki Kohno, et al.
International Journal of Oncology|September 3, 2009
Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cellsMasahiko Ajiro, Toyomasa Katagiri, Koji Ueda, et al.
Pageof 2